使用FDA不良事件报告系统 (FAERS) 数据库挖掘和分析guanfacine的不良事件概况
Lili Chen1, Qiaoyu Feng2, Qin Zhu2
1Department of Pediatrics, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Expert opinion on drug safety
|December 13, 2024
概括
这项研究使用FAERS数据识别了与guanfacine相关的新型不良事件 (AE),揭示了意外的安全信号,如杀人意念和生长失败,有助于合理的治疗实践.
科学领域:
- 药物监督 药物监督 药物监督
- 数据挖掘 数据挖掘
- 药品安全 药品安全
背景情况:
- 关法西因用于各种疾病,但其现实世界的安全性需要不断评估.
- 与guanfacine相关的不良事件 (AE) 需要全面分析以确保患者的安全.
研究的目的:
- 在现实环境中评估与guanfacine相关的不良事件 (AE).
- 识别新的安全信号,并为治疗实践提供指导.
主要方法:
- 从FAERS数据库 (2004年第一季度 - 2023年第四季度) 报告的关法辛相关副作用的回顾性分析.
- 使用不相称性分析,包括ROR,PRR,BCPNN和EBGM来检测显著的AE.
主要成果:
- 确定了2,709个首要疑似和8,464个关联关法辛的AE.
- 大多数副作用 (67.45%) 发生在治疗开始后的30天内.
- 检测到158个显著的PT,包括已知的事件和意想不到的信号,如谋杀思想,自我伤害思想,生长失败和过度眼.
结论:
- 发现了与guanfacine相关的新型不良事件信号.
- 这些发现可以指导在临床实践中合理和安全地使用关法辛.
相关概念视频
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Antiepileptic Drugs: Potassium Channel Activators
144
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
144
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Mania and Antimanic Drugs: Overview
135
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
135
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146


